SWP
TMO icon

Stratos Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Stratos Wealth Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.1M Buy
24,559
+130
+0.5% +$70.6K 0.14% 155
2025
Q4 		$14.2M Sell
24,429
-1,459
-6% -$825K 0.16% 126
2025
Q3 		$12.6M Buy
25,888
+1,074
+4% +$500K 0.15% 138
2025
Q2 		$10.1M Sell
24,814
-1,061
-4% -$444K 0.14% 155
2025
Q1 		$12.9M Sell
25,875
-237
-0.9% -$128K 0.2% 111
2024
Q4 		$13.6M Sell
26,112
-456
-2% -$251K 0.19% 103
2024
Q3 		$16.4M Buy
26,568
+488
+2% +$289K 0.24% 86
2024
Q2 		$14.4M Sell
26,080
-818
-3% -$469K 0.23% 86
2024
Q1 		$15.6M Buy
26,898
+731
+3% +$410K 0.26% 76
2023
Q4 		$13.9M Buy
26,167
+1,224
+5% +$592K 0.26% 73
2023
Q3 		$12.6M Buy
24,943
+782
+3% +$417K 0.27% 73
2023
Q2 		$12.6M Buy
24,161
+1,202
+5% +$649K 0.29% 70
2023
Q1 		$13.2M Sell
22,959
-974
-4% -$549K 0.35% 53
2022
Q4 		$13.2M Sell
23,933
-956
-4% -$507K 0.33% 63
2022
Q3 		$12.6M Buy
24,889
+435
+2% +$243K 0.35% 63
2022
Q2 		$13.3M Buy
24,454
+145
+0.6% +$79.8K 0.33% 64
2022
Q1 		$14.4M Buy
24,309
+633
+3% +$364K 0.32% 67
2021
Q4 		$15.8M Buy
23,676
+323
+1% +$202K 0.35% 51
2021
Q3 		$13.3M Buy
23,353
+112
+0.5% +$61.5K 0.34% 55
2021
Q2 		$11.7M Sell
23,241
-538
-2% -$254K 0.29% 66
2021
Q1 		$10.9M Buy
23,779
+316
+1% +$151K 0.3% 67
2020
Q4 		$10.9M Sell
23,463
-415
-2% -$195K 0.32% 60
2020
Q3 		$10.5M Buy
23,878
+421
+2% +$174K 0.35% 63
2020
Q2 		$8.5M Buy
23,457
+213
+0.9% +$71.4K 0.3% 72
2020
Q1 		$6.59M Buy
23,244
+394
+2% +$124K 0.3% 74
2019
Q4 		$7.42M Sell
22,850
-80
-0.3% -$24.3K 0.29% 71
2019
Q3 		$6.68M Buy
22,930
+569
+3% +$163K 0.29% 70
2019
Q2 		$6.57M Buy
22,361
+231
+1% +$63.6K 0.28% 70
2019
Q1 		$6.06M Buy
22,130
+500
+2% +$124K 0.27% 70
2018
Q4 		$4.84M Buy
21,630
+337
+2% +$79.1K 0.25% 85
2018
Q3 		$5.2M Buy
21,293
+145
+0.7% +$33.4K 0.23% 85
2018
Q2 		$4.38M Sell
21,148
-612
-3% -$130K 0.2% 109
2018
Q1 		$4.49M Buy
21,760
+1,633
+8% +$343K 0.19% 114
2017
Q4 		$3.82M Sell
20,127
-924
-4% -$177K 0.17% 127
2017
Q3 		$3.98M Buy
21,051
+667
+3% +$121K 0.19% 118
2017
Q2 		$3.56M Sell
20,384
-619
-3% -$104K 0.18% 124
2017
Q1 		$3.23M Buy
21,003
+1,079
+5% +$165K 0.18% 122
2016
Q4 		$2.81M Buy
19,924
+6,127
+44% +$903K 0.17% 123
2016
Q3 		$2.19M Buy
13,797
+2,293
+20% +$353K 0.15% 136
2016
Q2 		$1.7M Buy
11,504
+6,443
+127% +$951K 0.13% 159
2016
Q1 		$717K Buy
5,061
+167
+3% +$22.4K 0.06% 229
2015
Q4 		$694K Buy
4,894
+3,254
+198% +$434K 0.06% 234
2015
Q3 		$200K Sell
1,640
-2,194
-57% -$286K 0.03% 486
2015
Q2 		$497K Buy
3,834
+72
+2% +$9.39K 0.06% 258
2015
Q1 		$505K Buy
+3,762
New +$485K 0.06% 292

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Stratos Wealth Partners's TMO Position: Q1 2026 in Review

Stratos Wealth Partners increased its Thermo Fisher Scientific (TMO) stake by 0.53% in Q1 2026, buying an estimated $70.6K and bringing the position to 24,559 shares worth $12.1M. The position accounts for 0.14% of the portfolio, ranked #155.

Stratos Wealth Partners first reported a position in TMO in Q1 2015 and has held it in 45 quarters since. The position peaked at $16.4M in Q3 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Stratos Wealth Partners held 24,559 shares of Thermo Fisher Scientific worth $12.1M as of Q1 2026.
  • Stratos Wealth Partners bought 130 Thermo Fisher Scientific shares in Q1 2026, an estimated $70.6K.
  • Thermo Fisher Scientific made up 0.14% of Stratos Wealth Partners's portfolio in Q1 2026, its #155 holding.
  • Stratos Wealth Partners first reported a position in Thermo Fisher Scientific in Q1 2015 and has held it in 45 quarters since.
  • Stratos Wealth Partners's Thermo Fisher Scientific position peaked at $16.4M in Q3 2024.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.